Loading resource…

Womack Army Medical Center; Uniformed Services University of the Health Sciences; U.S. Army Special Operations Command
Thrombocytopenia is defined as a platelet count of less than 150 × 10^3 per μL and can arise from various mechanisms including decreased production, increased destruction, and splenic sequestration. The document outlines the clinical implications of different platelet count ranges and highlights conditions that may require emergency intervention. It also discusses the management of thrombocytopenia, including the use of thrombopoietin receptor agonists for patients undergoing invasive procedures.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Myeloproliferative Neoplasms
Same clinical topic · Hematology

MASTOCYTOSIS
Same clinical topic · Hematology

MYELODYSPLASTIC SYNDROMES: 2023 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT
Same clinical topic · Hematology

PERIPHERAL T-CELL LYMPHOMAS
Same clinical topic · Hematology

COMPARISON OF THE INTERNATIONAL CONSENSUS AND 5TH WHO EDITION CLASSIFICATIONS OF ADULT MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
Same clinical topic · Hematology

VEXAS SYNDROME: A COMPREHENSIVE REVIEW OF PATHOGENESIS, CLINICAL SPECTRUM, AND THERAPEUTIC STRATEGIES
Same clinical topic · Hematology

IRON DEFICIENCY
Same clinical topic · Hematology

MULTIPLE MYELOMA: 2026 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION AND MANAGEMENT
Same clinical topic · Hematology

ANTIDOTES FOR ANTICOAGULATION REVERSAL
Same clinical topic · Hematology